Your browser doesn't support javascript.
loading
The Effect of Oxidation on Berberine-Mediated CYP1 Inhibition: Oxidation Behavior and Metabolite-Mediated Inhibition.
Lo, Sheng-Nan; Shen, Chien-Chang; Chang, Chia-Yu; Tsai, Keng-Chang; Huang, Chiung-Chiao; Wu, Tian-Shung; Ueng, Yune-Fang.
Afiliação
  • Lo SN; Divisions of Basic Chinese Medicine (S.-N.L., C.-Y.C., C.-C.H., Y.-F.U.), Chinese Medicinal Chemistry (C.-C.S.), and Chinese Materia Medica Development (K.-C.T.), National Research Institute of Chinese Medicine, Taipei, Taiwan, Republic of China; Institute of Biopharmaceutical Sciences, School of Li
  • Shen CC; Divisions of Basic Chinese Medicine (S.-N.L., C.-Y.C., C.-C.H., Y.-F.U.), Chinese Medicinal Chemistry (C.-C.S.), and Chinese Materia Medica Development (K.-C.T.), National Research Institute of Chinese Medicine, Taipei, Taiwan, Republic of China; Institute of Biopharmaceutical Sciences, School of Li
  • Chang CY; Divisions of Basic Chinese Medicine (S.-N.L., C.-Y.C., C.-C.H., Y.-F.U.), Chinese Medicinal Chemistry (C.-C.S.), and Chinese Materia Medica Development (K.-C.T.), National Research Institute of Chinese Medicine, Taipei, Taiwan, Republic of China; Institute of Biopharmaceutical Sciences, School of Li
  • Tsai KC; Divisions of Basic Chinese Medicine (S.-N.L., C.-Y.C., C.-C.H., Y.-F.U.), Chinese Medicinal Chemistry (C.-C.S.), and Chinese Materia Medica Development (K.-C.T.), National Research Institute of Chinese Medicine, Taipei, Taiwan, Republic of China; Institute of Biopharmaceutical Sciences, School of Li
  • Huang CC; Divisions of Basic Chinese Medicine (S.-N.L., C.-Y.C., C.-C.H., Y.-F.U.), Chinese Medicinal Chemistry (C.-C.S.), and Chinese Materia Medica Development (K.-C.T.), National Research Institute of Chinese Medicine, Taipei, Taiwan, Republic of China; Institute of Biopharmaceutical Sciences, School of Li
  • Wu TS; Divisions of Basic Chinese Medicine (S.-N.L., C.-Y.C., C.-C.H., Y.-F.U.), Chinese Medicinal Chemistry (C.-C.S.), and Chinese Materia Medica Development (K.-C.T.), National Research Institute of Chinese Medicine, Taipei, Taiwan, Republic of China; Institute of Biopharmaceutical Sciences, School of Li
  • Ueng YF; Divisions of Basic Chinese Medicine (S.-N.L., C.-Y.C., C.-C.H., Y.-F.U.), Chinese Medicinal Chemistry (C.-C.S.), and Chinese Materia Medica Development (K.-C.T.), National Research Institute of Chinese Medicine, Taipei, Taiwan, Republic of China; Institute of Biopharmaceutical Sciences, School of Li
Drug Metab Dispos ; 43(7): 1100-7, 2015 Jul.
Article em En | MEDLINE | ID: mdl-25953522
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Berberina / Citocromo P-450 CYP1A2 / Citocromo P-450 CYP1B1 / Inibidores das Enzimas do Citocromo P-450 Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Berberina / Citocromo P-450 CYP1A2 / Citocromo P-450 CYP1B1 / Inibidores das Enzimas do Citocromo P-450 Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article